Position in TSHA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,160,487
+$7,050,487 QoQ
Shares Held
2,226,210
+22.7% QoQ
Ownership
0.683%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 208 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. TSHA ranks #93 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in TSHA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,160,487 | 2,226,210 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $8,110,000 | 1,814,318 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $6,808,927 | 1,237,987 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,615,170 | 1,717,178 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,069,390 | 1,328,741 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,990,014 | 1,431,666 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,523,605 | 1,458,732 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,758,774 | 1,372,525 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $606,514 | 270,766 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $606,702 | 211,395 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $378,285 | 213,721 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $209,160 | 66,190 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $48,225 | 72,958 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $58,220 | 72,958 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $164,885 | 72,958 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $77,059 | 39,927 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $144,414 | 38,821 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,340,673 | 205,625 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,504,398 | 214,970 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,946,098 | 211,928 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,215,809 | 198,859 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,967,555 | 96,924 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,740,467 | 103,258 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||